Skip to content

Clinical trials

Phase 1/2 Movement Disorders trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Movement Disorders Phase: Phase 1/2 Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20011
20061
20091
20172
20181
20191
20222
20252
20261

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed6
Recruiting2
Active, not recruiting1
Not yet recruiting1
Terminated1
Unknown status1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Herantis Pharma Plc.2
AskBio France, SAS, a subsidiary of AskBio Inc.1
BlackfinBio Ltd1
Hoffmann-La Roche1
National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS)1
Radboud University Medical Center1
Renishaw1
Sangamo Therapeutics1
São Paulo State University1
Teva Branded Pharmaceutical Products R&D, Inc.1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Movement Disorders12
Parkinson Disease7
Brain Diseases5
Neurodegenerative Diseases5
Nervous System Diseases4
Central Nervous System Diseases3
Dyskinesias2
Huntington Disease2
Parkinsonian Disorders2
Basal Ganglia Diseases1

Trials

Showing 26 to 12 of 12. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.